小鼠卵巢冷冻移植后卵泡发育和卵母细胞成熟的研究

本研究探讨了冷冻保存的1日龄小鼠卵巢异体异位移植后,其原始卵泡重新启动生长发育的能力。一日龄B6C2F．小鼠卵巢分离冷冻后置液氮中保存,保存1周。6个月后解冻,并将卵巢移植到8-12周龄B6C2F．受体鼠。肾脏包膜下,移植至少14d。每侧肾囊移植2枚卵巢的40只受体鼠中卵巢的回收率为45．00％（72／160）,而每侧。肾囊移植l枚卵巢的20只受体鼠的回收率为82．50％（33／40）。移植卵巢上卵泡的发育基本与体外自然生长鼠的卵巢卵泡发育情况一致。对卵巢移植19d的受体鼠用孕马血清促性腺激素（pregnant mare serum gonadotrophin,PMSG）处理后,从移植卵巢上发育成熟卵泡中获得的卵母细胞在MEM0c培养基中培养16-17h,有40．90％的卵母细胞发生生发泡破裂（germinal vesicle breakdown,GVBD）,其中89．02％的卵母细胞发育到第二次减数分裂中期（metaphaseⅡ,MⅡ）。将剩余的卵母细胞继续培养到20～21h,又有50．83％的卵母细胞发生生发泡破裂,但其中只有21．40％的卵母细胞能够发育到MII期。以上结果说明,小鼠早期卵巢经过冷冻．解冻并异体异位移植后,其原始卵泡能够重新启动生长发育,发育后的卵泡卵母细胞能够在体外培养成熟。这些结果意味着原始卵泡或卵巢冷冻一移植技术有可能充分利用雌性生殖细胞用于濒危动物保种、建立动物基因库和人类辅助生殖等。     

哺乳动物卵母细胞的冷冻保存方法

卵母细胞的冷冻保存与精子和胚胎的冷冻保存一样,具有许多潜在的应用价值。八十年代以后,卵母细胞体外成熟、体外受精、核移植,基因转移等相继研究成功。把优良品种动物废弃卵巢中的大量卵母细胞冷冻保存,可为这些生物技术提供充足的材料。卵母细胞的冷冻保存也为稀有动物,濒危动物和其它有价值的雌性个体(如基因工程个体)的遗传资源的长距离国际间运输及长期保存提供了可能。在人,卵母细胞冷冻保存可以克服胚胎冷冻保存所引起的一系列伦理道德及法律问题。     

哺乳动物卵母细胞异位发育技术及其研究进展

综述了哺乳动物卵巢移植在生物医学上的应用,及借助卵巢异位发育研究卵巢卵母细胞发育机制的研究进展;详细介绍了卵巢移植的不同技术方法,及移植后卵巢卵母细胞的发育、激素的调节机制,分析了卵巢移植早期卵泡生长和凋亡的分子机理及其在移植医学中的应用前景,并就新鲜和冻融卵巢如何用于动物辅助生殖进行了阐述.特别关注卵巢卵母细胞异种移植的潜在价值,卵巢异种移植不仅可以保存稀有和濒危物种,还可以为当前辅助生殖技术提供一个理想的实验手段.     

低温保存许旺细胞对周围神经再生的作用

目的：比较原代培养许旺细胞（Schwann cells,SCs)和冷冻保存的SCs移植对损伤后坐骨神经再生的作用。方法：原代培养和液氮保存的SCs分别移植到桥接缺损坐骨神经的硅胶管内。在移植后不同时间（第6和8周末）,硅胶管远端神经干内注射HRP,逆行追踪背根神经节和脊髓前角的标记神经元数量;测量再生神经纤维的复合动作电位传导速度;电镜观察再生神经纤维的髓鞘形成。结果：原代培养和冷冻保存SCs在移植后不同时间其背根神经节和脊髓前角神经元HRP标记细胞数量、再生神经纤维的复合动作电位传导速度基本一致,再生神经纤维髓鞘的形成未见明显差别。结论：冷冻保存的SCs仍具有促进损伤后周围神经再生的能力。     

去势大鼠新鲜、冷冻卵巢移植后激素代谢变化

目的观察去势大鼠经新鲜、冷冻卵巢移植后体内激素代谢变化情况。方法24只去势大鼠经右下腹皮下移植新鲜卵巢（3 d之内乳鼠卵巢）和经过冻存培养后的卵巢（3 d之内乳鼠卵巢）后,检测移植前、移植后1个月2、个月的三碘甲腺原氨酸（T3）、甲状腺素（T4）、促甲状腺激素（TSH）、睾酮（T）、雌二醇（E2）、孕酮（P）、黄体生成素（LH）及卵泡生成素（FSH）。结果冻存卵巢移植前与新鲜卵巢移植前比较：T值升高,有显著性差异（P〈0.01）;冻存卵巢移植后1个月与新鲜卵巢移植后1个月比较差异无显著性（P〉0.05）;冻存卵巢移植后2个月与新鲜卵巢移植后2个月比较：E2升高明显,差异具有显著性（P〈0.01;新鲜卵巢移植后2个月与移植前比较：T4,T,E2,P,LH均有明显升高（P〈0.01;P〈0.05）;冻存卵巢移植后2个月与移植前比较：E2,P增高明显（P〈0.01;P〈0.05）。结论冷冻卵巢移植较新鲜卵巢移植功能恢复明显。     

小鼠移植卵巢的生长及功能初探

实验对小鼠单侧和双侧自体异位移植的卵巢,运用组织学、组织化学和放射免疫技术,探讨其生长规律。结果表明：移植卵巢的生长可分三个阶段：（１）坏死期：移植第２～４天,卵巢的原有组织处于退化状态,仅边缘可见原始卵泡和窦前卵泡;（２）恢复期：移植第７～１４天,卵巢逐渐恢复正常结构,血清孕酮水平开始上升,大多数动物出现动情周期;（３）发育成熟期：移植第１４天以后,卵巢内含发育不同阶段的卵泡、黄体和大量间质腺,孕酮水平接近正常。单侧移植卵巢的生长比双侧推迟约７天。本研究显示自体异位移植卵巢能够生长发育并分泌雌性激素     

海藻酸微囊在细胞冷冻保存中的研究现状及应用

细胞的冷冻保存是细胞生物学实验中重要的实验技术.长期以来,人们使用冷冻保存液重悬细胞后进行冷冻储存,但是近年来,众多研究者发现传统冷冻方案往往会导致细胞活率大幅下降和细胞功能方面受损,从而很难满足生物医学、组织再生工程、细胞移植技术等高新技术的要求.所以研究者提出利用三维海藻酸微囊包埋细胞后再进行冷冻保存,从而在保证较高细胞活率的同时维持细胞的原有功能,有效的提高细胞的冷冻保存效率.本文概述了海藻酸微囊在细胞冷冻保存过程中的研究现状,同时对其应用进行了展望,以期为后续研究工作提供参考.     

雄性受体小鼠性腺对移植卵巢卵母细胞生长发育的影响

目的探索雄性受体性腺对移植卵巢卵母细胞生长发育的影响。方法将1日龄小鼠卵巢移植入成年雄鼠肾囊下,将雄性受体小鼠分为性腺摘除组和性腺在位组,于21d回收移植卵巢,以评价雄性小鼠性腺对新生小鼠卵巢移植体卵母细胞生长发育的影响。结果移植后21d,性腺摘除组和性腺在位组卵巢回收率分别为80.0%和92.9%,移植体生长增大;每个卵巢平均回收卵母细胞数分别为(30.4±4.3)和(42.4±11.1)个,两者差异不显著(P0.05);性腺摘除组回收的均为GV期卵母细胞,性腺在位组大部分为GV期卵母细胞,有的达到MII期。结论雄性受体小鼠能够支持移植卵巢卵母细胞的生长发育,雄性受体的性腺对其影响不明显。     

肌病小鼠卵巢正位移植技术

卵巢移植,国外已经做了很多工作。在移植技术方面积累了不少经验。出于不同的目的,卵巢组织可以正位移植,也可以异位移植于脑、眼前房、脾脏和皮下组织等部位。卵巢移植技术的建立,不仅在研究内分泌功能方面,而且在分析组织适合性的遗传学方面亦提供很大的方便。据报导已应用于下述研究工作:(1)研     

冻融小鼠卵巢移植后细胞凋亡及血管内皮生长因子表达的变化及意义研究

目的:探讨冻融小鼠卵巢同种异体移植后细胞凋亡及血管内皮生长因子表达的变化及意义。方法:收集C57BL/6j雌鼠和BALB/c雄鼠杂交后F1代4周龄小鼠卵巢,慢冻速融后移植至杂交后F1代8～12周雄鼠的肾被膜下,分别于移植后1d(24h)、2d(48h)和7d回收移植物,将冻融以及移植后不同时间段的卵巢组织进行HE染色、全卵巢卵泡计数、电镜观察、免疫组织化学分析细胞凋亡及RT-PCR检测VEGF基因表达。结果:冻融小鼠卵巢移植后随着时间的推移、各级卵泡数和卵泡存活率逐渐下降;移植后48h内细胞凋亡指数最高;电镜观察发现小鼠卵巢组织移植后损伤主要发生在移植后48h内;移植后VEGF的表达有上升的趋势,至第7d仍维持较高水平;移植后48hVEGF120mRNA和VEGF188mRNA水平明显升高(P0.05),至7d下降恢复至移植前水平,而VEGF164mRNA水平移植后无明显变化(P0.05)。结论:小鼠卵巢组织移植后48h内细胞凋亡最为严重,移植后引起大量卵泡的丢失;在移植后血管化的过程中VEGFmRNA表达量增加,VEGF120mRNA和VEGF188mRNA可能参与卵巢移植后早期血管化过程。     

Islet transplantation in experimental diabetes of the rat. VII. Cryopreservation of rat and human islets. Preliminary results

Islet transplantation in human diabetes at present is confronted with two major obstacles: isolation of a sufficient number of islets and islet graft rejection. "Tissue banking" would enable islet pooling from various donors and offers furthermore the advantage of in vitro manipulations in order to reduce islet immunogenicity. Recently we have reported successful cryopreservation and subsequent transplantation of porcine islets (Bretzel, Beule, Sch?fer, Schneider, Pfeiffer and Federlin 1979). These preliminary data deal with cryopreservation and transplantation of isolated rat islets and cryopreservation of isolated human islets.     

Cryopreservation of human brain tissue allowing timely production of viable adult human brain cells for autologous transplantation

BACKGROUND: Autologous transplantation is an attractive approach to treat some neurological diseases. A major obstacle is the capacity to produce cells for transplantation at the appropriate time. We describe a cryopreservation procedure for adult human brain tissue allowing the generation of cells in vitro. METHODS: Neurological resections were dissected to separate white and grey matter. Fractions were frozen in a specific cryopreservation medium containing a selected serum and stored in liquid nitrogen. Tissue was thawed, cells were mechanically dissociated, expanded in culture and characterized by immunochemistry. RESULTS: Adult human brain tissue cryopreserved for up to two years was successfully used to generate brain cells that could be maintained in culture for up to 100 days. Cells expressed a variety of neuroectodermal markers including GFAP, S100beta, and neurofilament. CONCLUSION: A successful procedure for cryopreservation of adult human brain tissue has been established that might facilitate future autologous transplantation strategies.     

Leukapheresis cell concentration adjustment required for a successful recovery of HSC after cryopreservation

The recovering of an adequate number of hematopoietic stem cells after cryopreservation is considered pivotal for successful transplantation. Various factors could influence the recovery of HSC following processing and cryopreservation. Therefore, leukapheresis product from thirty patients was cryopreserved in 10% DMSO in cryopreservation bags for their autologous bone marrow transplantation, and 2 ml were cryopreserved in cryovials for post-thaw viability assessment by flow cytometry. The percentage of viable HSCs recovered post-cryopreservation in leukapheresis product was significantly influenced by the concentration of the total nucleated cells cryopreserved per volume. Patients receiving a higher rate of viable HSCs resulted in earlier engraftment of both neutrophils and platelets, so they have been discharged earlier from the hospital. Furthermore, Storage temperature and duration played a role in the recovery of these cells and for the support of the findings, age of the patient at the time of collection did not show any impact on the recovery of this HSC post-cryopreservation. In conclusion, various influencing factors must be taken into consideration during the cryopreservation of HSCs, especially for poor mobilizing patients with a low number of collected hematopoietic stem cells.     

美洲鲥雄性生殖细胞冷冻保存及移植

采用分离细胞冻存和组织块直接冻存2种方法, 进行美洲鲥(American shad, Alosa sapidissima)精巢细胞的长时间冷冻保存(>250d), 并比较分析2种不同冻存方法对美洲鲥雄性生殖细胞的冻存效果。解冻复苏后用Hochest33342和PI共染细胞核, 分析统计各期雄性生殖细胞的存活率, 结果显示组织块冻存方法所得精原干细胞和精母细胞的存活率明显高于分离细胞冻存的; 而精细胞及其他细胞存活率在2种方法间无显著差异; 特别是, 镜检发现组织块冻存方法所得精子存活率高达93.83%, 说明此冻存方法能同时高效地冻存美洲鲥各期生殖细胞, 包括成熟的精子。同时, 将组织块冻存的美洲鲥生殖细胞用PKH26染色标记后移植到出苗第1天的斑马鱼仔鱼中, 在细胞植入后5d仍能在受体中检测到供体细胞, 且有部分供体细胞能与内源生殖细胞共定位, 表明经过长时间冷冻保存的美洲鲥生殖细胞仍具有生殖细胞特性, 且能整合到斑马鱼受体性腺原基。研究结果为进一步开展美洲鲥, 或其他洄游性鱼类的生殖细胞发育、培养及种质资源保存等研究工作奠定了技术理论基础。     

Effect of cryopreservation on lipid peroxidation in chick cornea.

A mechanism suggested to cause injury to the preserved organs in vitro is the generation of oxygen free radicals either during preservation or after transplantation due to reperfusion. Methods to suppress generation of oxygen free radicals may lead to improved methods of organ preservation. In this study, increase in the levels of lipid peroxidation in chick cornea after cryopreservation is reported. Addition of fetal bovine serum (FBS) in cryopreservation medium was found to prevent lipid peroxidation. Addition of FBS was also found to be protective towards corneal viability during cryopreservation.     

Preserved insulin secretion capacity and graft function of cryostored encapsulated rat islets

Encapsulation of pancreatic islets before transplantation enables survival and function in an immunocompetent recipient without immunosuppression. However, the insufficient availability of allogenic islet tissue is a major problem. One concept to overcome these shortcomings is the cryopreservation of microencapsulated allogenic islets, to allow their unlimited collection and use on demand. Therefore, this report outlines the development of a cryopreservation protocol for CD rat islets encapsulated in an alginate-based microcapsule-system. We determined RPMI-medium plus 10% FCS as freezing medium, equilibration at 0°C for 15 min with the cryoprotectant dimethyl sulfoxide (DMSO; final concentration 2.0M), and a stepwise removal of DMSO by sucrose dilution after thawing, as best protocol for cryopreservation of encapsulated islets. Importantly, the cryopreserved encapsulated islets showed post thawing in vitro an insulin increase upon a glucose challenge comparable to that of non-cryopreserved encapsulated islets. Moreover, a stable graft function without the need of immunosuppression was detected after transplantation of 2500 cryopreserved encapsulated CD rat islets in streptozotocin-diabetic Wistar rats. Finally, the glucose clearance rate during an IPGTT 4 weeks after transplantation was comparable to that of rats transplanted with non-cryopreserved encapsulated islets. In conclusion, our study demonstrates for the first time that cryopreservation of encapsulated rat islets is possible without substantial losses on graft function. Future studies will now have to carry on this approach to human islets, aiming to apply such a bioartificial pancreas consisting of cryopreserved encapsulated islets in humans.     

Cryopreservation of isolated human hepatocytes for transplantation: State of the art

Hepatocytes isolated from unused donor livers are being used for transplantation in patients with acute liver failure and liver-based metabolic defects. As large numbers of hepatocytes can be prepared from a single liver and hepatocytes need to be available for emergency and repeated treatment of patients it is essential to be able to cryopreserve and store cells with good thawed cell function. This review considers the current status of cryopreservation of human hepatocytes discussing the different stages involved in the process. These include pre-treatment of cells, freezing solution, cryoprotectants and freezing and thawing protocols. There are detrimental effects of cryopreservation on hepatocyte structure and metabolic function, including cell attachment, which is important to the engraftment of transplanted cells in the liver. Cryopreserved human hepatocytes have been successfully used in clinical transplantation, with evidence of replacement of missing function. Further optimisation of hepatocyte cryopreservation protocols is important for their use in hepatocyte transplantation.     

Cryopreservation of oocyte and ovarian tissue

Cryopreservation of reproductive cells (i.e., oocytes, spermatozoa) and tissues (i.e., ovarian and testicular tissue) is a developing technology that has tremendous implications for rapid advancement of biomedical research in general. Since the early 1980s, advances have been made in establishing optimal conditions for in vitro oocyte maturation, fertilization, and culture of resulting embryos. These in vitro systems have contributed significantly to the utilization of these cells and tissues after thawing and have made it possible to evaluate protocols designed to cryopreserve such biomaterials more effectively. Although cryopreservation of preimplantation embryos from various species including mouse, human, and farm animals has been successful, cryopreservation of oocytes from most mammalian species has been more challenging due to their extreme sensitivity to suboptimal conditions during the cryopreservation process. Cryopreservation on mouse oocytes have been well documented and have resulted in greater success than studies with other mammalian species. Ovarian tissue cryopreservation and transplantation techniques have recently received much scientific and public attention due to their great potential use in human infertility treatment, in safeguarding the reproductive potential of the endangered species, and in genome banking of genetically important lab animal strains. A review of past and current research in the field of oocyte and ovarian tissue cryopreservation and transplantation and discussion of possible strategies for oocyte and ovarian tissue banking are provided.     

Review of vitreous islet cryopreservation

Transplantation of pancreatic islets for the treatment of diabetes mellitus is widely anticipated to eventually provide a cure once a means for preventing rejection is found without reliance upon global immunosuppression. Long-term storage of islets is crucial for the organization of transplantation, islet banking, tissue matching, organ sharing, immuno-manipulation and multiple donor transplantation. Existing methods of cryopreservation involving freezing are known to be suboptimal providing only about 50% survival. The development of techniques for ice-free cryopreservation of mammalian tissues using both natural and synthetic ice blocking molecules, and the process of vitrification (formation of a glass as opposed to crystalline ice) has been a focus of research during recent years. These approaches have established in other tissues that vitrification can markedly improve survival by circumventing ice-induced injury. Here we review some of the underlying issues that impact the vitrification approach to islet cryopreservation and describe some initial studies to apply these new technologies to the long-term storage of pancreatic islets. These studies were designed to optimize both the pre-vitrification hypothermic exposure conditions using newly developed media and to compare new techniques for ice-free cryopreservation with conventional freezing protocols. Some practical constraints and feasible resolutions are discussed. Eventually the optimized techniques will be applied to clinical allografts and xenografts or genetically-modified islets designed to overcome immune responses in the diabetic host.